Research shows enhanced blood-forming ability in old stem cells through regeneration — Evidence Review

Scientists at the Icahn School of Medicine at Mount Sinai have shown that repairing lysosomal dysfunction can rejuvenate aged blood-forming stem cells in mice. Related research broadly supports the idea that stem cell aging can be reversed or mitigated by targeting intrinsic cell changes and the surrounding microenvironment.

• Multiple studies demonstrate that both intrinsic cellular mechanisms (such as lysosomal function, epigenetic changes, and cell cycle regulation) and extrinsic factors (including the bone marrow niche and systemic environment) contribute to hematopoietic stem cell (HSC) aging, and interventions in these areas can restore youthful stem cell traits 1 2 3 4 5 7 10.
• Experimental approaches, including modulating the bone marrow microenvironment, altering systemic factors, depleting aged stem cell subsets, and transferring cellular components from young to old cells, have all shown rejuvenating effects on HSCs, aligning with the new findings that lysosomal correction can restore function 1 2 3 4 5.
• There is consensus that stem cell aging is not strictly irreversible; both environmental and genetic interventions—such as those targeting lysosomal activity, autophagy, or the immune-inflammatory axis—can improve or reset stem cell function in aged models 3 4 5 8 10.

Study Overview and Key Findings

Aging is associated with a decline in the regenerative capacity of hematopoietic stem cells (HSCs), leading to impaired blood and immune cell production and increased vulnerability to infections and blood-related diseases in older adults. This study addresses a critical question: can the aging process in blood-forming stem cells be reversed? By focusing on the role of lysosomes—the cell’s recycling centers—the researchers provide new insights into cellular mechanisms driving stem cell aging and identify potential therapeutic targets for rejuvenation. Notably, the study moves beyond general observations of stem cell decline by demonstrating that correcting lysosomal dysfunction can restore the function of aged HSCs.

Property	Value
Organization	Icahn School of Medicine at Mount Sinai, Imagine Institute, INSERM UMR 1163, Université de Paris Cité
Journal Name	Cell Stem Cell
Authors	Saghi Ghaffari, Mickaël Ménager
Population	Mice
Methods	Animal Study
Outcome	Lysosomal activity, stem cell regeneration, blood cell production
Results	Old stem cells' blood-forming ability increased by over eightfold.

Literature Review: Related Studies

To contextualize these findings, we searched the Consensus paper database, which aggregates over 200 million research papers. The following search queries were used to identify relevant literature:

1. old blood stem cells rejuvenation
2. stem cell age-related changes
3. blood-forming ability stem cell research

Summary Table of Key Topics from Related Studies

Topic	Key Findings
How reversible is hematopoietic stem cell aging?	- Rejuvenation of aged HSCs can be achieved through interventions targeting cell-intrinsic pathways (e.g., lysosomal function, autophagy, epigenetic state) 3 5 8 10. - Both environmental and genetic interventions can restore youthful function in aged stem cells 2 3 10.
What role does the microenvironment or niche play in stem cell aging and rejuvenation?	- Aging of bone marrow endothelial and stromal components impairs HSC function; modifying the niche or transplanting young niche cells can restore HSC activity 1 2 5. - The systemic environment, including factors in young blood, can revitalize aged stem cells 3 5.
What cellular and molecular mechanisms drive HSC aging and can they be targeted?	- Age-related changes include increased inflammation, altered cell cycle, DNA damage, and metabolic shifts; targeting these (e.g., by depleting myeloid-biased HSCs or correcting lysosomal dysfunction) improves HSC function 4 7 10. - Modulation of autophagy and lysosomal activity impacts rejuvenation 5 10.
What are the clinical implications for transplantation and therapy?	- Ex vivo rejuvenation of aged stem cells or niche cells may expand donor pools and improve transplantation outcomes 2 5 6. - Understanding reversible aspects of stem cell aging could inform therapies for age-related blood disorders and immune deficiencies 6 8 13.

---

How reversible is hematopoietic stem cell aging?

A growing body of evidence suggests that aging in hematopoietic stem cells is not an irreversible process. Interventions targeting both intrinsic cell pathways—such as lysosomal function, autophagy, and epigenetic regulation—and extrinsic signals from the niche or systemic environment have demonstrated the ability to restore youthful characteristics to aged HSCs. The new study is consistent with this literature, offering a mechanistic approach through targeting lysosomal dysfunction.

• Reversal of stem cell aging has been achieved in animal models through exposure to young systemic environments (heterochronic parabiosis) or by correcting cell-intrinsic defects 3 10.
• Ex vivo rejuvenation methods, including transfer of microvesicles from young stromal cells, restore function in aged HSCs 5.
• Epigenetic modifications and metabolic interventions can reset aged stem cell programs to a more youthful state 8 10.
• The new study’s focus on lysosomal correction adds a specific mechanistic target to these broader strategies 10.

What role does the microenvironment or niche play in stem cell aging and rejuvenation?

The bone marrow microenvironment, or niche, is increasingly recognized as a key regulator of HSC aging. Age-related deterioration in niche components—such as endothelial and stromal cells or sympathetic innervation—adversely affects HSC function. The rejuvenation of aged HSCs via manipulation of the niche or systemic factors is well-supported by related studies, and the new research provides complementary evidence by targeting an intrinsic stem cell pathway.

• Restoration of sympathetic nerve signaling or transplantation of young endothelial cells has been shown to rejuvenate aged HSC function 1 2.
• Microvesicle transfer from young niche cells to aged HSCs can rescue their regenerative capacity 5.
• The systemic environment (e.g., factors in young blood) can reverse age-associated declines in stem cell and immune function 3.
• These findings underscore the interplay between stem cell-intrinsic and -extrinsic aging mechanisms 1 2 3 5.

What cellular and molecular mechanisms drive HSC aging and can they be targeted?

Multiple molecular mechanisms underlie HSC aging, including increased inflammation, DNA damage, changes in cell cycle dynamics, and metabolic alterations. Targeting these pathways—such as by depleting pro-inflammatory or myeloid-biased HSCs, correcting lysosomal dysfunction, or restoring autophagy—has been shown to rejuvenate old stem cells, which aligns with the new study’s lysosomal focus.

• Depletion of myeloid-biased HSCs restores youthful immune features and adaptive responses in aged mice 4.
• Single-cell transcriptomics reveal that aging HSCs display altered cell cycle progression and differentiation programs 7.
• Enhancing autophagy or correcting lysosomal function in aged HSCs improves their regenerative ability 5 10.
• The present study’s findings that lysosomal correction leads to improved metabolism, epigenetics, and reduced inflammation are consistent with these mechanisms 4 5 7 10.

What are the clinical implications for transplantation and therapy?

Understanding and reversing stem cell aging has direct implications for transplantation, donor eligibility, and therapies for age-related blood and immune disorders. Ex vivo rejuvenation techniques, such as those targeting lysosomal or autophagy pathways, could expand the use of older donors and improve patient outcomes.

• Rejuvenated HSCs or supportive niche cells from young donors enhance hematopoietic recovery and survival after transplantation or injury 2 5.
• Age-related decline in mesenchymal stem cell fitness may limit therapy efficacy in older patients, highlighting the importance of rejuvenation strategies 6.
• The evidence that some aspects of stem cell aging are reversible could inform new approaches for treating hematological diseases and improving immune function in elderly patients 6 8 13.
• The new study’s ex vivo approach demonstrates the potential for practical application in regenerative medicine and transplantation 2 5 6.

Future Research Questions

Further research is needed to translate these findings from animal models to humans, clarify the long-term safety and efficacy of lysosomal-targeted interventions, and explore broader implications for aging and cancer risk. The following table outlines several key questions for future investigation:

Research Question	Relevance
Can lysosomal targeting rejuvenate aged human hematopoietic stem cells?	Demonstrating similar effects in human cells is crucial for clinical translation; existing studies have mostly focused on murine models 5 6 9.
What are the long-term risks of rejuvenating old stem cells, such as cancer formation?	Some age-associated changes may act as tumor suppressive barriers; reversing them could have unintended consequences, including increased cancer risk 8 9.
How does lysosomal dysfunction interact with the bone marrow niche during aging?	Interplay between intrinsic (lysosomal) and extrinsic (niche) factors may be important in determining stem cell fate and rejuvenation potential 1 2.
Can ex vivo lysosomal modulation improve hematopoietic stem cell transplantation outcomes in the elderly?	Improving transplantation efficacy could expand donor eligibility and benefit older patients; related studies suggest ex vivo modification is promising 2 5 6.
Does targeting lysosomal activity affect the development of leukemic stem cells or clonal hematopoiesis?	As clonal hematopoiesis and leukemia risk increase with age, understanding how lysosomal interventions influence these processes is essential for safety and efficacy 8 9.